The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports research to understand, treat, and prevent infectious and allergic diseases.

2021年6月21日 · Three research divisions at NIAID direct and manage grants, contracts, and cooperative agreements that support research at external academic and research institutions (known as extramural research): Division of AIDS (DAIDS)

2023年12月6日 · NIH Versus NIAID: Funding Strategy and Paylines. NIH sets a fiscal policy for grants every year and issued the most recent one in a February 3, 2023 Guide notice. The notice sets certain rules, but ICs set their own funding strategies for how to use their appropriated funds. We post NIAID's funding strategies at Financial Management Plan.

2023年12月19日 · Biodefense and Emerging and Re-emerging Infectious Diseases. NIAID research provides the foundation for developing medical products and strategies to diagnose, treat, and prevent a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism.

The National Institute of Allergy and Infectious Diseases (NIAID, / ˈ n aɪ. æ d /) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS).

1 天前 · News releases, fact sheets and other NIAID-related materials are available on the NIAID website. About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and ...

The National Institute of Allergy and Infectious Diseases (NIAID) provides health information on allergic, infectious, and immunologic diseases. Diseases include food allergy, sinusitis, and genital herpes.

2024年12月19日 · Through a variety of research grants and contracts, NIAID’s Division of Microbiology and Infectious Diseases (DMID) specifically supports extramural research to develop new medical countermeasures (MCMs) against potential agents of bioterrorism, drug-resistant pathogens, and emerging and re-emerging infectious diseases.

2023年4月21日 · Develop strategies to prevent and treat immunologic, allergic, and infectious diseases; A strong clinical research component is integral to the DIR, allowing key lab discoveries to be rapidly translated into methods to prevent, diagnose, or treat disease.

The National Institute of Allergy and Infectious Diseases (NIAID) has made significant investments into basic, translational, and clinical research on AR. ... instructions by the Center for Scientific Review and responsiveness by the National Institute of Allergy and Infectious Diseases, NIH. Applications that are incomplete, non-compliant and ...